PARP inhibitors in ovarian cancer: What are the next steps?

Date 10 October 2016
Event ESMO 2016 Congress
Session Advances in targeted therapy in gynaecological cancers
Topics Cytotoxic agents
Ovarian Cancer
Therapy
Biological therapy
Presenter Jonathan Ledermann
Authors J.A. Ledermann
  • Cancer Research Uk And Ucl Cancer Trials Centre, University College London Cancer Institute, WC1E6BT - London/GB